Omnicare (OCR) Declares Quarterly Dividend of $0.14

Omnicare (NYSE:OCR) declared a quarterly dividend on Wednesday, May 29th, AnalystRatings.Net reports. Shareholders of record on Monday, June 3rd will be given a dividend of $0.14 per share on Friday, June 14th. This represents a $0.56 dividend on an annualized basis and a yield of 1.20%. The ex-dividend date of this dividend is Thursday, May 30th.

On a related note, analysts at Cowen Securities reiterated an “outperform” rating on shares of Omnicare in a research note to investors on Tuesday, March 12th.

Shares of Omnicare (NYSE: OCR) opened at 46.51 on Thursday. Omnicare has a 52 week low of $29.24 and a 52 week high of $47.45. The stock’s 50-day moving average is currently $43.97. The company has a market cap of $4.880 billion and a P/E ratio of 26.50.

Omnicare (NYSE: OCR) last announced its earnings results on Wednesday, April 24th. The company reported $0.90 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.85 by $0.05. The company had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.54 billion. During the same quarter in the prior year, the company posted $0.81 earnings per share. The company’s quarterly revenue was down 4.3% on a year-over-year basis. Omnicare has set its FY13 guidance at $3.47-3.57 EPS. On average, analysts predict that Omnicare will post $3.55 earnings per share for the current fiscal year.

Omnicare, Inc. (NYSE: OCR) is a pharmaceutical services company.

Latest News

Brokerages Expect Lendingtree Inc  Will Post Quarterly Sales of $207.79 Million
Brokerages Expect Lendingtree Inc Will Post Quarterly Sales of $207.79 Million
Grupo Financiero Galicia  Rating Increased to Hold at Zacks Investment Research
Grupo Financiero Galicia Rating Increased to Hold at Zacks Investment Research
$65.06 Million in Sales Expected for TPG Specialty Lending Inc  This Quarter
$65.06 Million in Sales Expected for TPG Specialty Lending Inc This Quarter
EncryptoTel [ETH]  Reaches One Day Volume of $10,783.00
EncryptoTel [ETH] Reaches One Day Volume of $10,783.00
CrowdWiz   Trading 16.1% Lower  This Week
CrowdWiz Trading 16.1% Lower This Week
Revance Therapeutics Inc  Expected to Post Quarterly Sales of $1.74 Million
Revance Therapeutics Inc Expected to Post Quarterly Sales of $1.74 Million


© 2006-2018 Ticker Report